Mimura K - Search Results

1

Immunotherapy for esophageal squamous cell carcinoma: a review.

Mimura K, Yamada L, Ujiie D, Hayase S, Tada T, Hanayama H, Thar Min AK, Shibata M, Momma T, Saze Z, Ohki S, Kono K. Mimura K, et al. Fukushima J Med Sci. 2018 Aug 29;64(2):46-53. doi: 10.5387/fms.2018-09. Epub 2018 Jul 27. Fukushima J Med Sci. 2018. PMID: 30058598 Free PMC article. Review.

2

Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma.

Mimura K, Kono K, Hanawa M, Mitsui F, Sugai H, Miyagawa N, Ooi A, Fujii H. Mimura K, et al. Br J Cancer. 2005 Apr 11;92(7):1253-60. doi: 10.1038/sj.bjc.6602499. Br J Cancer. 2005. PMID: 15785739 Free PMC article. Clinical Trial.

3

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.

Kono K, Kawaida H, Takahashi A, Sugai H, Mimura K, Miyagawa N, Omata H, Fujii H. Kono K, et al. Among authors: mimura k. Cancer Immunol Immunother. 2006 Sep;55(9):1064-71. doi: 10.1007/s00262-005-0092-8. Epub 2005 Nov 23. Cancer Immunol Immunother. 2006. PMID: 16328385 Free PMC article.

4

Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma.

Kawaguchi Y, Kono K, Mimura K, Mitsui F, Sugai H, Akaike H, Fujii H. Kawaguchi Y, et al. Among authors: mimura k. Br J Cancer. 2007 Aug 20;97(4):494-501. doi: 10.1038/sj.bjc.6603885. Epub 2007 Jul 10. Br J Cancer. 2007. PMID: 17622245 Free PMC article.

5

CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.

Maruyama T, Kono K, Izawa S, Mizukami Y, Kawaguchi Y, Mimura K, Watanabe M, Fujii H. Maruyama T, et al. Among authors: mimura k. Dis Esophagus. 2010 Jul;23(5):422-9. doi: 10.1111/j.1442-2050.2009.01029.x. Epub 2009 Dec 11. Dis Esophagus. 2010. PMID: 20002703

6

Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma.

Watanabe M, Kono K, Kawaguchi Y, Mizukami Y, Mimura K, Maruyama T, Fujii H. Watanabe M, et al. Among authors: mimura k. Br J Cancer. 2010 Feb 2;102(3):520-9. doi: 10.1038/sj.bjc.6605502. Epub 2009 Dec 22. Br J Cancer. 2010. PMID: 20029417 Free PMC article.

7

NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma.

Watanabe M, Kono K, Kawaguchi Y, Mizukami Y, Mimura K, Maruyama T, Izawa S, Fujii H. Watanabe M, et al. Among authors: mimura k. Dis Esophagus. 2010 Nov;23(8):675-81. doi: 10.1111/j.1442-2050.2010.01073.x. Dis Esophagus. 2010. PMID: 20545975

8

Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma.

Maruyama T, Mimura K, Sato E, Watanabe M, Mizukami Y, Kawaguchi Y, Ando T, Kinouchi H, Fujii H, Kono K. Maruyama T, et al. Among authors: mimura k. Br J Cancer. 2010 Aug 10;103(4):552-9. doi: 10.1038/sj.bjc.6605772. Epub 2010 Jul 13. Br J Cancer. 2010. PMID: 20628381 Free PMC article.

9

Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.

Kono K, Mimura K, Kiessling R. Kono K, et al. Among authors: mimura k. Cell Death Dis. 2013 Jun 20;4(6):e688. doi: 10.1038/cddis.2013.207. Cell Death Dis. 2013. PMID: 23788045 Free PMC article. Review.

10

Implication of Highly Cytotoxic Natural Killer Cells for Esophageal Squamous Cell Carcinoma Treatment.

Lim KS, Mimura K, Kua LF, Shiraishi K, Kono K. Lim KS, et al. Among authors: mimura k. J Immunother. 2018 Jul/Aug;41(6):261-273. doi: 10.1097/CJI.0000000000000227. J Immunother. 2018. PMID: 29683892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

581 results

Search Page

Filters